1
|
Schett G and Gravallese E: Bone erosion in
rheumatoid arthritis: Mechanisms, diagnosis and treatment. Nat Rev
Rheumatol. 8:656–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Crotti TN, Dharmapatni AA, Alias E,
Zannettino AC, Smith MD and Haynes DR: The immunoreceptor
tyrosine-based activation motif (ITAM)-related factors are
increased in synovial tissue and vasculature of rheumatoid
arthritic joints. Arthritis Res Ther. 14:R2452012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wong JB, Ramey DR and Singh G: Long-term
morbidity, mortality, and economics of rheumatoid arthritis.
Arthritis Rheum. 44:2746–2749. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lajas C, Abasolo L, Bellajdel B,
Hernández-García C, Carmona L, Vargas E, Lázaro P and Jover JA:
Costs and predictors of costs in rheumatoid arthritis: A
prevalence-based study. Arthritis Rheum. 49:64–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ouyang Q, Wu J, Jiang Z, Zhao J, Wang R,
Lou A, Zhu D, Shi GP and Yang M: Microarray expression profile of
circular RNAs in peripheral blood mononuclear cells from rheumatoid
arthritis patients. Cell Physiol Biochem. 42:651–659. 2017.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Guan R and Mariuzza RA: Peptidoglycan
recognition proteins of the innate immune system. Trends Microbiol.
15:127–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Royet J and Dziarski R: Peptidoglycan
recognition proteins: Pleiotropic sensors and effectors of
antimicrobial defences. Nat Rev Microbiol. 5:264–277. 2007.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Dziarski R and Gupta D: Review: Mammalian
peptidoglycan recognition proteins (PGRPs) in innate immunity.
Innate Immun. 16:168–174. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Luo Q, Zeng L, Mei H, Huang Z, Luo X, Ye
J, Li X, Guo Y and Li J: PD-L1-expressing neutrophils as a novel
indicator to assess disease activity of rheumatoid arthritis. Int J
Clin Exp Med. 10:7716–7724. 2017.
|
10
|
Villanueva-Romero R, Gutiérrez-Cañas I,
Carrión M, Pérez-García S, Seoane IV, Martínez C, Gomariz RP and
Juarranz Y: The anti-inflammatory mediator, vasoactive intestinal
peptide, modulates the differentiation and function of th subsets
in rheumatoid arthritis. J Immunol Res. 2018:60437102018.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Calabresi E, Petrelli F, Bonifacio AF,
Puxeddu I and Alunno A: One year in review 2018: Pathogenesis of
rheumatoid arthritis. Clin Exp Rheumatol. 36:175–184.
2018.PubMed/NCBI
|
12
|
Fodil M, Teixeira VH, Chaudru V, Hilliquin
P, Bombardieri S, Balsa A, Westhovens R, Barrera P, Alves H,
Migliorin P, et al: Relationship between SNPs and expression level
for candidate genes in rheumatoid arthritis. Scand J Rheumatol.
44:2–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma
L and Jiang Y: High frequencies of activated B cells and T
follicular helper cells are correlated with disease activity in
patients with new-onset rheumatoid arthritis. Clin Exp Immunol.
174:212–220. 2013.PubMed/NCBI
|
15
|
Prevoo ML, van't Hof MA, Kuper HH, van
Leeuwen MA, van de Putte LB and van Riel PL: Modified disease
activity scores that include twenty-eight-joint counts. Development
and validation in a prospective longitudinal study of patients with
rheumatoid arthritis. Arthritis Rheum. 38:44–48. 1995. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hochberg MC: Updating the American College
of rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Luo Q, Zhang L, Li X, Fu B, Deng Z, Qing
C, Su R, Xu J, Guo Y, Huang Z and Li J: Identification of circular
RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for
rheumatoid arthritis. Clin Exp Immunol. 194:118–124. 2018.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhang F, Wu L, Qian J, Qu B, Xia S, La T,
Wu Y, Ma J, Zeng J, Guo Q, et al: Identification of the long
noncoding RNA NEAT1 as a novel inflammatory regulator acting
through MAPK pathway in human lupus. J Autoimmun. 75:96–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Park HJ, Noh JH, Eun JW, Koh YS, Seo SM,
Park WS, Lee JY, Chang K, Seung KB, Kim PJ and Nam SW: Assessment
and diagnostic relevance of novel serum biomarkers for early
decision of ST-elevation myocardial infarction. Oncotarget.
6:12970–12983. 2015.PubMed/NCBI
|
20
|
Alemao E, Guo Z, Frits ML, Iannaccone CK,
Shadick NA and Weinblatt ME: Association of anti-cyclic
citrullinated protein antibodies, erosions, and rheumatoid factor
with disease activity and work productivity: A patient registry
study. Semin Arthritis Rheum. 47:630–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Haschka J, Englbrecht M, Hueber AJ, Manger
B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S,
Feuchtenberger M, et al: Relapse rates in patients with rheumatoid
arthritis in stable remission tapering or stopping anti-rheumatic
therapy: Interim results from the prospective randomized controlled
RETRO study. Ann Rheum Dis. 75:45–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Tydell CC, Yuan J, Tran P and Selsted ME:
Bovine peptidoglycan recognition protein-S: antimicrobial activity,
localization, secretion, and binding properties. J Immunol.
176:1154–1162. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kedar MP, Acharya RV and Prakashini K:
Performance of the 2010 American College of Rheumatology/European
League against Rheumatism (ACR/EULAR) criteria for classification
of rheumatoid arthritis in an Indian population: An observational
study in a single centre. Indian J Med Res. 144:288–292. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Falkenburg WJJ, Kempers AC, Dekkers G,
Ooijevaar-de Heer P, Bentlage AEH, Vidarsson G, van Schaardenburg
D, Toes REM, Scherer HU and Rispens T: Rheumatoid factors do not
preferentially bind to ACPA-IgG or IgG with altered
galactosylation. Rheumatology (Oxford). 56:2025–2030. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Schett G: The role of ACPAs in at-risk
individuals: Early targeting of the bone and joints. Best Pract Res
Clin Rheumatol. 31:53–58. 2017. View Article : Google Scholar : PubMed/NCBI
|